Free Trial

Vivos Therapeutics (VVOS) Insider Trading & Ownership

Vivos Therapeutics logo
$4.01 -0.02 (-0.50%)
(As of 12/5/2024 ET)

Vivos Therapeutics (NASDAQ:VVOS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.00%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
$46,660.00
Number Of
Insiders Selling
(Last 3 Years)
0
Get VVOS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Vivos Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

VVOS Insider Buying and Selling by Quarter

Vivos Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/20/2023Ronald Kirk HuntsmanCEOBuy560$13.25$7,420.00  
6/16/2023Ronald Kirk HuntsmanCEOBuy600$13.50$8,100.00  
6/14/2023Ronald Kirk HuntsmanCEOBuy400$12.25$4,900.00  
12/23/2022Ronald Kirk HuntsmanCEOBuy800$12.50$10,000.00  
5/31/2022Ronald Kirk HuntsmanCEOBuy320$50.75$16,240.00  
(Data available from 1/1/2013 forward)

VVOS Insider Trading Activity - Frequently Asked Questions

The list of insiders at Vivos Therapeutics includes Ronald Kirk Huntsman. Learn more on insiders at VVOS.

3.00% of Vivos Therapeutics stock is owned by insiders. Learn more on VVOS's insider holdings.

The following insider purchased VVOS shares in the last 24 months: Ronald Kirk Huntsman ($30,420.00).

Insiders have purchased a total of 2,360 VVOS shares in the last 24 months for a total of $30,420.00 bought.

Vivos Therapeutics Key Executives



This page (NASDAQ:VVOS) was last updated on 12/5/2024 by MarketBeat.com Staff
From Our Partners